Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5935595B2 - Angiotensin converting enzyme activity measurement method - Google Patents
[go: Go Back, main page]

JPS5935595B2 - Angiotensin converting enzyme activity measurement method - Google Patents

Angiotensin converting enzyme activity measurement method

Info

Publication number
JPS5935595B2
JPS5935595B2 JP13151480A JP13151480A JPS5935595B2 JP S5935595 B2 JPS5935595 B2 JP S5935595B2 JP 13151480 A JP13151480 A JP 13151480A JP 13151480 A JP13151480 A JP 13151480A JP S5935595 B2 JPS5935595 B2 JP S5935595B2
Authority
JP
Japan
Prior art keywords
converting enzyme
angiotensin converting
activity
measuring
nadph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13151480A
Other languages
Japanese (ja)
Other versions
JPS5758896A (en
Inventor
靖 笠原
義弘 芦原
孝博 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Rebio Kk
Original Assignee
Fuji Rebio Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Rebio Kk filed Critical Fuji Rebio Kk
Priority to JP13151480A priority Critical patent/JPS5935595B2/en
Publication of JPS5758896A publication Critical patent/JPS5758896A/en
Publication of JPS5935595B2 publication Critical patent/JPS5935595B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明はアンジオテンシン変換酵素の活性を測定する方
法に関し、下記式で示される合成基質pとヒプリカーゼ
とp−ヒドロキシ安息香酸水酸化酵素を用いることを特
徴とするアンジオテンシン変換酵素の活性測定法に関す
る。
Detailed Description of the Invention The present invention relates to a method for measuring the activity of angiotensin converting enzyme, which is characterized in that it uses a synthetic substrate p represented by the following formula, hiplicase, and p-hydroxybenzoic acid hydroxylase. Concerning a method for measuring the activity of.

アンジオテンシン変換酵素(以下ACEと略記する)は
、生体内においてアンジオテンシンIに作用し、C−末
端のジペプチドすなわちL−ヒス−ヒドロキシヒプリル
ーL−グリシルーL−グリシンJH−CH2−C−NH
−CH2−COOHチジルーL−ロイシンを遊離せしめ
て、血圧上昇作用のあるアンジオテンシン■を生成する
酵素である。
Angiotensin-converting enzyme (hereinafter abbreviated as ACE) acts on angiotensin I in vivo, and has a C-terminal dipeptide, namely L-his-hydroxyhypri-L-glycyl-L-glycine JH-CH2-C-NH
-CH2-COOH This is an enzyme that liberates tidyl-L-leucine and generates angiotensin (2), which has an effect of increasing blood pressure.

この酵素はレニン・アンジオテンシン系あるいはキニン
・カリクレーン系と関連して生体内で重要な役割をして
いるが、この酵素の血中でのレベルによつてサルコイド
ーシスの診断をすることができる。従つて上記ACEの
酵素活性を測定することは生理的あるいは臨床的に有意
義であり、従来その測定法として、(1)放射性同位元
素を用いる方法、(2)螢光を用いる方法、(3)液体
クロマトグラフイ一による方法などが提案されているが
、これらの方法は特殊な装置を必要とするために一般的
な方法として用いられていない。
This enzyme plays an important role in the body in association with the renin-angiotensin system or the kinin-kallikrene system, and sarcoidosis can be diagnosed based on the level of this enzyme in the blood. Therefore, it is physiologically or clinically meaningful to measure the enzymatic activity of ACE, and the conventional methods for this measurement include (1) a method using radioisotopes, (2) a method using fluorescence, and (3) a method using fluorescence. Although methods using liquid chromatography have been proposed, these methods require special equipment and are therefore not commonly used.

また上記の方法のほかに、カツシユマンらの提案した方
法があり、この方法では合成基質ヒプリル一L−ヒスチ
ジル一L−ロイシンを用い、これをACEを含有してい
る試料(例えば血清、体液など)と所定時間反応せしめ
た後、反応停止剤例えば塩酸を添加し、先成したヒプリ
ル酸を酢酸エチルで抽出し、酢酸エチルを蒸発して乾固
した後、蒸留水に溶解し、紫外部において吸光度を測定
してモプリル酸の濃度を求め、これから計算によつてA
CEの活性を求める。本発明は上記の方法と異なり、A
CEの活性を簡単に測定する方法を提供することを目的
として開発されたものであつて、本発明の測定法の原理
は次の通りである。
In addition to the above method, there is a method proposed by Katsyuman et al., which uses the synthetic substrate hipryl-L-histidyl-L-leucine and transfers it to samples containing ACE (e.g. serum, body fluids, etc.). After reacting for a predetermined period of time, a reaction terminator such as hydrochloric acid is added, and the preformed hyperric acid is extracted with ethyl acetate. After evaporating the ethyl acetate to dryness, it is dissolved in distilled water, and the absorbance is measured under ultraviolet light. is measured to determine the concentration of moprilic acid, and from this, A is calculated.
Determine the activity of CE. The present invention differs from the above method in that A
It was developed with the aim of providing a method for easily measuring CE activity, and the principle of the measuring method of the present invention is as follows.

血清、体液などACEを含有する液体に、既述した式で
示されるp−ヒドロキシヒプリル一L−グリシル−L−
グリシンを加えると、p−ヒドロキシヒプリル酸とL−
グリシル−L−グリシンを生ずる。
In liquids containing ACE such as serum and body fluids, p-hydroxyhypril-L-glycyl-L-
When glycine is added, p-hydroxyhyprilic acid and L-
yields glycyl-L-glycine.

これにヒプリカーセを加えると、p−ヒドロキシ安息香
酸とグリシンを生ずる。p−ヒドロキシ安息香酸はp−
ヒドロキシ安息香酸水酸化酵素およびNADPH(ニコ
チンアミドアデニンージヌクレオチドリン酸還元型)の
存在下で、3・4−ジヒドロキシ安息香酸とNADP゛
とを生ずる。消費するNADPHの吸光度の減少を測定
することによつて、上記ACEの活性を知ることができ
る。従つて上記のp−ヒドロキシヒプリル一L−グリシ
ル−L−グリシン、ヒプリカーゼ、p−ヒドロキシ安息
香酸水酸化酵素及びNADPHを含有する溶液を試薬と
し、これにACEを含有する液体例えば血清を混合し、
NADPHの吸光度の減少を分光法によつて測定し、N
ADPHの消費量を求めACEの活性を算定することが
できる。
Adding hipricase to this produces p-hydroxybenzoic acid and glycine. p-hydroxybenzoic acid is p-
In the presence of hydroxybenzoic acid hydroxylase and NADPH (nicotinamide adenine dinucleotide phosphate reduced form), 3,4-dihydroxybenzoic acid and NADP' are produced. The activity of the ACE can be determined by measuring the decrease in the absorbance of consumed NADPH. Therefore, the above solution containing p-hydroxyhypril-L-glycyl-L-glycine, hypercase, p-hydroxybenzoic acid hydroxylase, and NADPH is used as a reagent, and a liquid containing ACE, such as serum, is mixed therewith. ,
The decrease in absorbance of NADPH was measured by spectroscopy and
The activity of ACE can be calculated by determining the consumption amount of ADPH.

またこの他に高感度の活性測定法として NADPHの螢光を測定する方法を用いることもできる
In addition, a method of measuring NADPH fluorescence can also be used as a highly sensitive activity measuring method.

このように本発明の方法によれば、少量の試料を用いて
短時間で測定することができ、高感度で、極めて簡単に
ACEの活性を測定することができる。本発明の方法の
原理を式をもつて示すと次のとおりである。
As described above, according to the method of the present invention, it is possible to perform measurement in a short time using a small amount of sample, and the activity of ACE can be measured extremely easily with high sensitivity. The principle of the method of the present invention is expressed by the following formula.

上述したように(3)で消費されるNADPHの吸光度
の減少を、紫外部(340nm)においてまたはけい光
を用いて測定する。
The decrease in absorbance of NADPH consumed in (3) as described above is measured in the ultraviolet (340 nm) or using fluorescence.

下記に本発明の実施例を示す。Examples of the present invention are shown below.

例 p−ヒドロキシヒプリル一L−グリシル−L−グリシン
10mM)ヒプリカーゼIU,.p−ヒドロキシ安息香
酸水酸化酵素3U、NADPHO.2mM、ホウ酸0.
IMおよびNaClO.IMを含有する試薬溶液(PH
8.3)0.25ゴに対して、血清0.05mjおよび
希釈用精製水0.049ゴを加えて混合し、温度37℃
で波長340nmの光を用い、吸光度の減少を測定した
Example p-hydroxyhypril-L-glycyl-L-glycine 10mM) hiplicase IU, . p-hydroxybenzoic acid hydroxylase 3U, NADPHO. 2mM, boric acid 0.
IM and NaClO. Reagent solution containing IM (PH
8.3) Add 0.05 mj of serum and 0.049 mj of purified water for dilution to 0.25 mj, mix, and heat at 37°C.
The decrease in absorbance was measured using light with a wavelength of 340 nm.

測定は遠心方式による自動分析機を用い、タイムラグを
5秒、反応時間を10分とした。
The measurement was performed using an automatic analyzer using a centrifugal method, with a time lag of 5 seconds and a reaction time of 10 minutes.

ACEの活性単位MUは次式によつて求めた。20回測
定を行なつた結果は次に示すとおりであつた。
The activity unit MU of ACE was determined by the following formula. The results of 20 measurements were as shown below.

本発明の方法と比較するために、上記例において用いた
血清と同じ血清を用い、次のようにしてカツシユマン方
法によつて測定を行ない、下記に示す結果を得た。
For comparison with the method of the present invention, measurements were carried out by the Katschmann method as follows using the same serum as used in the above example, and the results shown below were obtained.

ヒプリル一L−ヒスチジル一L−ロイシンを含むリン酸
緩衝液( PH= 8.3)0.25m1に血清0.1
m1を加えて混合し、37℃において60分間反応せし
めた後、塩酸を加えて反応を停止させ、反応生成物であ
るヒプリル酸を抽出するため酢酸エチル1.5m1を加
えてふりまぜ、上清を採取し、溶媒を除去した後、所定
の精製水で復元し、比色計によつて波長228nmの紫
外線の吸光度を測定し、ヒプリル酸の生成量を求め、A
CEの活性単位MUを計算した。
0.1 serum in 0.25 ml of phosphate buffer (PH = 8.3) containing hipryl-L-histidyl-L-leucine
After adding 1.5 ml of ethyl acetate and mixing, and reacting at 37°C for 60 minutes, add hydrochloric acid to stop the reaction, add 1.5 ml of ethyl acetate to extract the reaction product, hipric acid, and mix. After removing the solvent, reconstitute with specified purified water, measure the absorbance of ultraviolet rays with a wavelength of 228 nm using a colorimeter, determine the amount of hyperlic acid produced, and
The activity unit MU of CE was calculated.

20回測定した結果は次の通りであつた。The results of 20 measurements were as follows.

上記結果から判るように、本発明の方法はカツシユマン
の方法に比べてはるかに簡単であるが活性単位において
は、カツシユマンの方法の場合とほぼ同じ値が得られ、
変動係数においてはカツシユマンの方法の場合に比して
その値が小さく、再現性においてすぐれている。
As can be seen from the above results, the method of the present invention is much simpler than Katsuyuman's method, but in terms of activity units, almost the same value as Katsuyuman's method is obtained.
The coefficient of variation is smaller than that of Katschmann's method, and the reproducibility is excellent.

Claims (1)

【特許請求の範囲】 1 下記式で示される合成基質p−ヒドロキシヒプリル
−L−グリシル−L−グリシン、ヒプリカーゼ、p−ヒ
ドロキシ安息香酸水酸化酵素およびNADPH(ニコチ
ンアミド アデニン ジヌクレオチド リン酸還元型)
を含有する溶液を、アンジオテンシン変換酵素を含有す
る液体に混合し、消費されるNADPHの吸光度を分光
法によつて測定する段階を含むことを特徴とするアンジ
オテンシン変換酵素の活性測定法。 ▲数式、化学式、表等があります▼
[Scope of Claims] 1 Synthetic substrates p-hydroxyhypril-L-glycyl-L-glycine, hypercase, p-hydroxybenzoic acid hydroxylase and NADPH (nicotinamide adenine dinucleotide phosphate reduced form) represented by the following formula: )
A method for measuring the activity of angiotensin converting enzyme, comprising the steps of: mixing a solution containing the angiotensin converting enzyme with a liquid containing the angiotensin converting enzyme, and measuring the absorbance of consumed NADPH by spectrometry. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
JP13151480A 1980-09-24 1980-09-24 Angiotensin converting enzyme activity measurement method Expired JPS5935595B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13151480A JPS5935595B2 (en) 1980-09-24 1980-09-24 Angiotensin converting enzyme activity measurement method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13151480A JPS5935595B2 (en) 1980-09-24 1980-09-24 Angiotensin converting enzyme activity measurement method

Publications (2)

Publication Number Publication Date
JPS5758896A JPS5758896A (en) 1982-04-08
JPS5935595B2 true JPS5935595B2 (en) 1984-08-29

Family

ID=15059813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13151480A Expired JPS5935595B2 (en) 1980-09-24 1980-09-24 Angiotensin converting enzyme activity measurement method

Country Status (1)

Country Link
JP (1) JPS5935595B2 (en)

Also Published As

Publication number Publication date
JPS5758896A (en) 1982-04-08

Similar Documents

Publication Publication Date Title
Chiknas A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.
Spencer Analytical reviews in clinical biochemistry: the estimation of creatinine
Cooper Methods for determining the amount of glucose in blood
Witteveen et al. Kinetic properties of the isoenzymes of human creatine phosphokinase
Neels et al. Sensitive colorimetric assay for angiotensin converting enzyme in serum.
US5288606A (en) Reagent for specific determination of fructosamine
Rowsell et al. Assays for glyoxylate aminotransferase activities
US4000042A (en) Diagnostic reagent for the determination of amylase
Dupuy et al. Rapid determination of alpha-amylase activity by use of a new chromogenic substrate.
CN107870170B (en) A kind of kit of luminol chemiluminescence analysis measurement glycated albumin
Gordeladze et al. A simple procedure for the determination of hydroxyproline in urine and bone
US4001089A (en) Method for determination of triglycerides and glycerol
Junnosuke et al. Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer
JPS584918B2 (en) Method for measuring glutamate-oxaloacetate-transaminase and glutamate-pyruvate-transaminase
Watson Enzymic determination of glucose and easily hydrolyzable glucose esters in blood
EP0041089A2 (en) Improved chromogenic method of detecting endotoxins in blood
JPS588839B2 (en) Angiotensin converting enzyme activity measurement method
Price et al. Analytical reviews in clinical biochemistry: the measurement of urate
Sugiura et al. Enzymic determination of serum oxalate
McKay Pentose estimation by the orcinol method, with particular reference to plasma pentose
Kingsley et al. Investigation of nuclear fast red method of Baar for direct spectrophotometric determination of calcium in serum, urine, and spinal fluid
JPS5935595B2 (en) Angiotensin converting enzyme activity measurement method
Rietz et al. Fluorometric assay of serum acid or alkaline phosphatase, either in solution or on a semisolid surface
JPS5823080B2 (en) Angiotensin converting enzyme activity measurement method
JPS5935594B2 (en) Angiotensin converting enzyme activity measurement method